Hamblin Michael R, Viveiros Jennifer, Yang Changming, Ahmadi Atosa, Ganz Robert A, Tolkoff M Joshua
Wellman Center for Photomedicine, Massachusetts General Hospital, 40 Blossom Street, BAR314B, Boston, Massachusetts 02114-2698, USA.
Antimicrob Agents Chemother. 2005 Jul;49(7):2822-7. doi: 10.1128/AAC.49.7.2822-2827.2005.
Helicobacter pylori colonizes the mucus layer of the human stomach and duodenum, causes chronic gastritis, gastric ulcer, and is a risk factor for gastric adenocarcinoma. There is a 20% failure rate in antibiotic therapy, which is increasingly due to antibiotic resistance and necessitates the search for alternative antimicrobial methods. We have discovered that H. pylori when cultured in liquid medium, accumulates significant quantities of coproporphyrin and protoporphyrin IX, both in the cells and secreted into the medium. These photoactive porphyrins lead to cell death (up to 5 logs) by photodynamic action upon illumination with low doses of visible light, with blue/violet light being most efficient. The degree of killing increases with the age of the culture and is greater than that found with Propionibacterium acnes (another bacterium known to be photosensitive due to porphyrin accumulation). Both virulent and drug-resistant strains are killed. The data suggest that phototherapy might be used to treat H. pylori infection in the human stomach.
幽门螺杆菌定殖于人类胃和十二指肠的黏液层,可引发慢性胃炎、胃溃疡,是胃腺癌的一个风险因素。抗生素治疗存在20%的失败率,这越来越多地归因于抗生素耐药性,因此有必要寻找替代抗菌方法。我们发现,幽门螺杆菌在液体培养基中培养时,会在细胞内积累大量粪卟啉和原卟啉IX,并分泌到培养基中。这些光活性卟啉在低剂量可见光照射下通过光动力作用导致细胞死亡(高达5个对数级),其中蓝/紫光最为有效。杀伤程度随培养时间的延长而增加,且大于痤疮丙酸杆菌(另一种因卟啉积累而具有光敏性的细菌)。有毒力菌株和耐药菌株均可被杀死。数据表明,光疗可能用于治疗人类胃部的幽门螺杆菌感染。